| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |